Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
12/2007
12/26/2007EP1870405A1 Carbonylated (Aza)cyclohexanes as dopamine D3 receptor ligands
12/26/2007EP1870401A1 1,4-substituted piperazine derivative
12/26/2007EP1870396A1 Benzyloxypropylamine derivative
12/26/2007EP1868999A1 Pyridine-3-carboxamide derivatives as cb1 inverse agonists
12/26/2007EP1597248B1 Sulfonamide derivatives as ppar modulators
12/26/2007EP1532112B1 Process for the preparation of modification i of n-(1-methylethylaminocarbonyl)-4-(3-methylphenylamino)-3-pyridinesulfonamide
12/26/2007EP0804428B1 Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors
12/26/2007CN200995996Y Pyridine light chlorinator of normal-pressure pipeline gas-phased
12/26/2007CN101094860A Metal complex compound and organic electroluminescent element using the same
12/26/2007CN101094835A Novel dicarboxamide derivatives
12/26/2007CN101092399A Method for preparing ionic liquid with anion being as ion in halogen family
12/26/2007CN101092394A Method for preparing Meixianduoxin
12/26/2007CN101092393A Method for preparing a category of compound of trifluoro methylpyridine
12/26/2007CN101092392A Method for preparing 2,3 ¿C dichloro ¿C 5 ¿C trichloro methylpyridine
12/26/2007CN101092391A Method for preparing 2,3 ¿C dichloro ¿C 5 ¿C trichloro methylpyridine
12/26/2007CN100357326C Method for producing aqueous polymer dispersions containing colorants
12/26/2007CN100357277C 1,2,4-triazole derivative, method for preparing the same, and pharmaceutical composition containing the same
12/26/2007CN100357273C Process for the production of substituted nicotinic acid esters
12/26/2007CN100357272C 2,3-dichloropyridine synthesis method
12/25/2007US7312358 Dysmenorrhea; congestive heart failure; liver disorders; vision defects
12/25/2007US7312336 Ligands for the delta opiod receptor; novel compounds which possess a piperidine ring with an exocyclic double bond do not show significant convulsive effects when administered systemically
12/25/2007US7312246 Inhibiting interaction of alpha-helical protein with another protein or binding site; inhibiting cellular invasion of HIV
12/25/2007US7312245 controlling harmful drug resistant fungi at lower concentrations; safe for crops; rice blast
12/25/2007US7312236 Inhibiting dural protein extravasation; migraines
12/25/2007US7312235 Anticoagulants
12/25/2007US7312234 Chemokine receptor binding heterocyclic compounds
12/25/2007US7312233 4-(2,2-dichlorocyclopropyl)-N-(quinolin-3-yl)benzamide; (1R,2R)2-methyl-N-(quinolin-3-yl)-4-(2-(trifluoromethyl)cyclopropyl)benzamide; inflammation-related conditions in mammals, arthritis, Parkinson's disease, Alzheimer's disease, stroke, asthma; acute/chronic or neuropathic pain; VR1 agonist/antagonist
12/25/2007US7312214 Anticoagulants; atherosclerosis; strokes; thrombosis; cardiovascular disorders
12/25/2007US7312181 Acylated thiosemicarbazides as herbicides
12/25/2007US7311736 Use of tetra-azapentamethine compounds as direct dyeing agents and novel tetra-azapentamethine compounds
12/21/2007WO2007144639A1 2 -oxybenzamide derivatives as parp inhibitors
12/21/2007WO2007144579A1 N-oxides of diarylurea derivatives and their use as chk1 inhibitors for the treatment of cancer
12/21/2007WO2007144204A1 Substituted aminopyrazolopyridines and salts thereof, their preparations and pharmaceutical compositions comprising them
12/21/2007WO2007144203A1 Substituted arylpyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
12/21/2007WO2007126771A3 Monocyclic and bicyclic himbacine derivatives useful as thrombin receptor antagonists
12/21/2007WO2007123939A3 Novel arylamino n-heteraryls as mek inhibitors
12/21/2007WO2007115269A3 Orally bioavailable caffeic acid related anticancer drugs
12/21/2007WO2007111705A3 Benzeneszkfibate salts and their use as intermediates for the synthesis of 2-[2-(1-alkyl-2-piperidyl)ethyl] cinnamanilides
12/21/2007WO2007099509A3 Primary amines as renin inhibitors
12/21/2007WO2007012761A8 Novel polysubstituted 1,1-pyridinyl aminocyclopropanamine derivatives, method for preparing same and pharmaceutical compositions containing same
12/21/2007WO2006103342A8 Indanyl-piperazine derivatives, method for preparing same and pharmaceutical compositions containing same
12/21/2007CA2655146A1 Benzamide derivatives and uses related thereto
12/21/2007CA2654789A1 Substituted aminopyrazolopyridines and salts thereof, their preparations and pharmaceutical compositions comprising them
12/21/2007CA2654515A1 Substituted 3-cyanopyridines as protein kinase inhibitors
12/21/2007CA2654105A1 Substituted arylpyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
12/21/2007CA2653039A1 Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics
12/21/2007CA2650666A1 Substituted cyanopyridines as protein kinase inhibitors
12/20/2007US20070293678 Process For The Preparation Of 6, 8-Subs Tituted '1, 7 Naphthpyridin Derivatives By Reacting The 8-Halo-'1, 7 Naphthpyrid In-Derivate With An Organic Boronic Acid Derivatives And Intermadiates Of This Process
12/20/2007US20070293544 Novel 4-Arylamino Pyridone Derivatives as Mek Inhibitors for the Treatment of Hyper-Proliferative Disorders
12/20/2007US20070293542 Selective Cox-2 Inhibitors
12/20/2007US20070293540 for hepatitis C; histone deacetylase inhibitors; N-hydroxy-4-{[(naphthyl-carbonylamino]alkoxy}benzamides; anticarcinogenic agent; acute promyelocytic leukemia; cell-cycle arrest in late G1 phase or at the G2/M transition
12/20/2007US20070293529 Tetrasubstituted ureas as modulators of 11-beta hydroxyl steroid dehydrogenase type 1
12/20/2007US20070293501 Thioalkeneamides as Transketolase Inhibitors
12/20/2007US20070293498 used for the treatment of cachexia and other weight loss disorders, such as those resulting from cancer, HIV, old age and anorexia nervosa
12/20/2007US20070293495 to treat Alzheimer's disease,Down syndrome and the other diseases associated with amyloid deposition; thiomethane, sulfinylmethane or sulfonylmethane compounds; 5-Chloro-4-[(4-chlorophenylsulfonyl)-(2,5-difluorophenyl)methyl]-2-(4'-hydroxypiperidin-1'-yl)pyridine
12/20/2007US20070293491 Indazole compounds and methods for inhibition of cdc7
12/20/2007US20070293483 Acetyl 2-hydroxy-1, 3-diaminoalkanes
12/20/2007US20070292933 Inhibitors of serine proteases, particular HCV NS3-NS4A protease
12/20/2007US20070292713 Electroluminescent iridium compounds with fluorinated phenylpyridine ligands, and devices made with such compounds
12/19/2007EP1867648A1 Substituted aminopyrazolopyridines and salts thereof, their preparations and pharmaceutical compositions comprising them.
12/19/2007EP1867645A1 Variolin derivatives and their use as antitumor agents
12/19/2007EP1867636A1 Pyridylmethylsulfone derivative
12/19/2007EP1867633A1 Polyamine analogues as therapeutic and diagnostic agents
12/19/2007EP1866298A2 Hydroxysteroid dehydrogenase inhibitors
12/19/2007EP1866286A1 Pyridine derivatives useful as inhibitors of pkc-theta
12/19/2007EP1866278A1 Substituted aryloxoethyl cyclopropanecarboxamide compounds as vr1 receptor antagonists
12/19/2007EP1865940A2 Alpha ketoamide compounds as cysteine protease inhibitors
12/19/2007EP1701946B1 Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the faah enzyme
12/19/2007EP1697336B1 Aroylfuranes and aroylthiophenes suitable for the treatment of cancer
12/19/2007EP1664031B1 Adamantane and azabicyclo-octane and nonane derivatives process of their preparation and their use as dpp-iv inhibitors
12/19/2007EP1656351B1 Process for preparation of 4-aryl-nicotinamide derivatives
12/19/2007EP1497261B1 Phenethanolamine derivatives
12/19/2007EP1490062B1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/19/2007EP1339665B1 Nitroderivatives as drugs for diseases having an inflammatory basis
12/19/2007EP1326856B1 Pyridine derivatives with ikb-kinase (ikk-beta) inhibiting activity
12/19/2007EP1115693B9 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL $i(TERTIARY)-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY
12/19/2007EP1032556B1 Pharmaceutically active compounds and methods of use
12/19/2007CN101090883A Substituted hydroxyethylamines
12/19/2007CN100355752C 6-methylpyridine derivatives, method for preparing thereof and antiviral pharmaceutical composition comprising the same
12/19/2007CN100355733C Industrialized method for preparing 2-chlorine-5-fluorin-nicotinic aicd
12/19/2007CN100355732C Preparation of 2-Cl-5-F-nicotinate and nicotonic acid
12/19/2007CN100355731C Pyridinum derivatives for management of aging-related and diabetic vascular complications, process for their prepn. and therepeutic uses thereof
12/19/2007CN100355730C Method for the production of nicotinaldehydes
12/19/2007CN100355728C Inhibitors of dipeptidyl peptidase IV
12/19/2007CN100355724C Multidentate ligand, polynuclear metal complex, metal complex chain, metal complex assembly and production thereof
12/19/2007CN100355721C Analogous compounds of strobilurines and their use as acaricides and insecticides
12/19/2007CN100355714C Arylpiperazines having 5-hydroxyl-typtamine activity
12/18/2007US7309800 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors
12/18/2007US7309702 4-(3-Phenyl-3-carbocycloylpropyl)-1-phenyl- or pyridylpiperazine derivatives: 1-(2-methoxyphenyl)-4-[3-(benzoyl)-3-(phenyl)propyl]piperazine oxalate; serotonin receptor antagonists; Alzheimer's disease
12/13/2007WO2007143422A2 Substituted pyridyl amide compounds as modulators of the histamine h3 receptor
12/13/2007WO2007141529A1 Fluoridation method
12/13/2007WO2007141473A1 N-(benzoyl)-o- [2- (pyridin- 2 -ylamino) ethyl] -l-tyrosine derivatives and related compounds as a5b1 antagonists for the treatment of solid tumors
12/13/2007WO2007141200A1 Novel n-aryl and n-heteroaryl substituted pyridinone derivatives for use in mch-1 mediated diseases
12/13/2007WO2007119001A3 Aminomethyl pyridine derivatives, method for preparing same and therapeutic use thereof
12/13/2007WO2007117981A3 Selective hydroxamate based mmp inhibitors
12/13/2007US20070287738 Substituted Cyanopyridines as protein kinase inhibitors
12/13/2007US20070287710 Piperidinediyl-containing sulfonamide; NPY Y5 receptor antagonist activity; antiobesity agent or anorectic agent
12/13/2007US20070287697 Cgrp Receptor Antagonists
12/13/2007US20070286842 serine protease inhibitors, for the treatment of hepatitis c virus infections
12/13/2007DE102006026431A1 Preparing an alkyl compound, useful e.g. in agrochemical industries, comprises reaction of a phenyl-halogen compound with an alcoholate compound or an alcohol compound and a base in presence of a copper-containing catalyst and a ligand
1 ... 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 ... 633